Literature DB >> 24221904

Relationship between endothelial vasomotor function and strut coverage after implantation of drug-eluting stent assessed by optical coherence tomography.

Hoyoun Won1, Jung-Sun Kim, Dong-Ho Shin, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Myeong-Ki Hong.   

Abstract

The use of drug-eluting stent (DES) has been associated with incomplete endothelialization and coronary endothelial dysfunction. However, the relationship between endothelial vasomotor function and strut coverage evaluated by optical coherence tomography (OCT) has not been sufficiently assessed. Therefore, we evaluated the relationship between endothelial vasomotor function and the degree of stent strut coverage after DES implantation. Coronary angiography and OCT were performed in 112 patients at the 6-month follow-up after DES implantation. The patients were divided into tertiles according to the degree of strut coverage as was assessed by OCT. Endothelial vasomotor function was evaluated with intracoronary infusion of incremental doses of acetylcholine (Ach; 10(-8)-10(-6) mol/L). Vascular responses at the proximal and distal segments to the stent margin were evaluated by quantitative coronary angiography analysis before and after Ach infusion. The percentage of uncovered struts in tertiles 1-3 was 4.2 ± 3.3, 17.3 ± 4.2 and 44.5 ± 14.4 %, respectively, (p < 0.001). The percentage of maximal vasoconstriction in tertiles 1-3 was 8.3, 9.1 and 8.1 % at proximal segment to the stent margin (p = 0.95), respectively, and 13.9, 11.1 and 14.2 % at distal segment to the stent margin (p = 0.74), respectively. The percentage of uncovered struts was not correlated with the degree of vasomotor function (r = -0.01, p = 0.92 at the proximal segment; r = -0.07, p = 0.47 at the distal segment). The percentage of strut coverage was not associated with the degree of abnormal vasoconstriction in response to intracoronary infusion of Ach 6 months after DES implantation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24221904     DOI: 10.1007/s10554-013-0325-4

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  27 in total

1.  Coronary endothelial dysfunction following sirolimus-eluting stent placement: should we worry about it?

Authors:  Amir Lerman; Eric Eeckhout
Journal:  Eur Heart J       Date:  2005-11-08       Impact factor: 29.983

2.  Endothelial dysfunction associated with drug-eluting stents what, where, when, and how?

Authors:  Joseph B Muhlestein
Journal:  J Am Coll Cardiol       Date:  2008-06-03       Impact factor: 24.094

3.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

Authors:  Michael Joner; Aloke V Finn; Andrew Farb; Erik K Mont; Frank D Kolodgie; Elena Ladich; Robert Kutys; Kristi Skorija; Herman K Gold; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2006-05-05       Impact factor: 24.094

4.  An optical coherence tomography study of two new generation stents with biodegradable polymer carrier, eluting paclitaxel vs. biolimus-A9.

Authors:  Periklis A Davlouros; Eleni Mavronasiou; Ioanna Xanthopoulou; Vasileios Karantalis; Grigorios Tsigkas; George Hahalis; Dimitrios Alexopoulos
Journal:  Int J Cardiol       Date:  2011-01-08       Impact factor: 4.164

5.  A -786T>C polymorphism in the endothelial nitric oxide synthase gene reduces serum nitrite/nitrate levels from the heart due to an intracoronary injection of acetylcholine.

Authors:  Masafumi Nakayama; Michihiro Yoshimura; Tomohiro Sakamoto; Koji Abe; Megumi Yamamuro; Makoto Shono; Satoru Suzuki; Tsunenori Nishijima; Yoshihiro Miyamoto; Yoshihiko Saito; Kazuwa Nakao; Hirofumi Yasue; Hisao Ogawa
Journal:  Pharmacogenet Genomics       Date:  2006-05       Impact factor: 2.089

6.  Endothelial dysfunction and restenosis following percutaneous coronary intervention.

Authors:  Panuratn Thanyasiri; Krishna Kathir; David S Celermajer; Mark R Adams
Journal:  Int J Cardiol       Date:  2006-11-07       Impact factor: 4.164

7.  Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent.

Authors:  Jin Won Kim; Soon Yong Suh; Cheol Ung Choi; Jin Oh Na; Eung Ju Kim; Seung-Woon Rha; Chang Gyu Park; Hong Seog Seo; Dong Joo Oh
Journal:  JACC Cardiovasc Interv       Date:  2008-02       Impact factor: 11.195

8.  Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion.

Authors:  Michalis I Hamilos; Miodrag Ostojic; Branko Beleslin; Dragan Sagic; Ljubco Mangovski; Sinisa Stojkovic; Milan Nedeljkovic; Dejan Orlic; Bratislav Milosavljevic; Dragan Topic; Nevena Karanovic; William Wijns
Journal:  J Am Coll Cardiol       Date:  2008-06-03       Impact factor: 24.094

9.  Delayed neointimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography.

Authors:  Hiroki Katoh; Junya Shite; Toshiro Shinke; Daisuke Matsumoto; Yusuke Tanino; Daisuke Ogasawara; Takahiro Sawada; Naoki Miyoshi; Hiroyuki Kawamori; Naoki Yoshino; Ken-ichi Hirata
Journal:  Circ J       Date:  2009-04-14       Impact factor: 2.993

10.  Comparison of optical coherence tomographic assessment between first- and second-generation drug-eluting stents.

Authors:  Byeong-Keuk Kim; Jung-Sun Kim; Junbeom Park; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Yonsei Med J       Date:  2012-05       Impact factor: 2.759

View more
  5 in total

Review 1.  Effects of Catheterization on Artery Function and Health: When Should Patients Start Exercising Following Their Coronary Intervention?

Authors:  Andrea Tryfonos; Daniel J Green; Ellen A Dawson
Journal:  Sports Med       Date:  2019-03       Impact factor: 11.136

Review 2.  Cardiovascular imaging 2013 in the International Journal of Cardiovascular Imaging.

Authors:  Hiram G Bezerra; Ricardo A Costa; Johan H C Reiber; Frank J Rybicki; Paul Schoenhagen; Arthur A Stillman; Johan De Sutter; Nico R L Van de Veire
Journal:  Int J Cardiovasc Imaging       Date:  2014-04       Impact factor: 2.357

3.  Current State of Bioabsorbable Polymer-Coated Drug-Eluting Stents.

Authors:  Abhilash Akinapelli; Jack P Chen; Kristine Roy; Joseph Donnelly; Keith Dawkins; Barbara Huibregtse; Dongming Hou
Journal:  Curr Cardiol Rev       Date:  2017

4.  Multianalysis with optical coherence tomography and vasomotion in everolimus-eluting stents and everolimus-eluting biovascular scaffolds: the MOVES trial.

Authors:  Diego A Arroyo; Sara Schukraft; Zacharenia Kallinikou; Jean-Christophe Stauffer; Gérard Baeriswyl; Jean-Jacques Goy; Mario Togni; Stéphane Cook; Serban Puricel
Journal:  Open Heart       Date:  2018-01-03

5.  Coronary Endothelium-Dependent Vasomotor Function After Drug-Eluting Stent and Bioresorbable Scaffold Implantation.

Authors:  Josep Gomez-Lara; Loreto Oyarzabal; Luis Ortega-Paz; Salvatore Brugaletta; Rafael Romaguera; Neus Salvatella; Gerard Roura; Fernando Rivero; Lara Fuentes; Fernando Alfonso; Imanol Otaegui; Bert Vandeloo; Beatriz Vaquerizo; Manel Sabate; Josep Comin-Colet; Joan-Antoni Gomez-Hospital
Journal:  J Am Heart Assoc       Date:  2021-11-03       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.